APA (7th ed.) Citation

A, K., YC, C., F, B., TH, W., N, X., CC, Y., . . . S, L. (2026). Risk for Cancer With Glucagon-Like Peptide-1 Receptor Agonists and Dual Agonists: A Systematic Review and Meta-analysis. Annals of internal medicine, 179(2), 216. https://doi.org/10.7326/ANNALS-25-02237

Chicago Style (17th ed.) Citation

A, Ko, et al. "Risk for Cancer With Glucagon-Like Peptide-1 Receptor Agonists and Dual Agonists: A Systematic Review and Meta-analysis." Annals of Internal Medicine 179, no. 2 (2026): 216. https://doi.org/10.7326/ANNALS-25-02237.

MLA (9th ed.) Citation

A, Ko, et al. "Risk for Cancer With Glucagon-Like Peptide-1 Receptor Agonists and Dual Agonists: A Systematic Review and Meta-analysis." Annals of Internal Medicine, vol. 179, no. 2, 2026, p. 216, https://doi.org/10.7326/ANNALS-25-02237.